Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium citrate 3g/10mL mixture BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate 3g/sachet granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate 12g/10mL concentrated mixture (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid + potassium citrate + sodium citrate 334mg/550mg/500mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate + sodium citrate 334mg/550mg/500mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate + sodium citrate 334mg/550mg/500mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate + sodium citrate dihydrate 334mg/550mg/500mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate 334mg/1100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citric acid monohydrate + potassium citrate 334mg/1100mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citric acid- and potassium citrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium citrate monohydrate (substance) |
Is a |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium citrate monohydrate (substance) |
Is modification of (attribute) |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate 12g/10mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium citrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only citric acid and potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium citrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing citric acid and potassium citrate and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citric acid- and potassium citrate- and sodium citrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only citric acid and potassium citrate and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citric acid and potassium citrate and sodium citrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium citrate 3 gram/1 sachet granules for conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium citrate 3 gram/1 sachet granules for conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium citrate anhydrous |
Is modification of (attribute) |
True |
Potassium citrate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|